Strumento inattivo

Azioni Omthera Pharmaceuticals Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	20/09/13
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	16/07/13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	09/07/13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	27/06/13
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13/06/13

Settore

	Variaz. 1 gen.	Capi.
MERCK KGAA	+7,39%	72,09 Mrd
KYOWA KIRIN CO. LTD.	+15,93%	9,05 Mrd
SK BIOPHARMACEUTICALS CO., LTD.	-22,81%	4,4 Mrd
YUHAN CORPORATION	+17,59%	4,39 Mrd
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+25,93%	3,94 Mrd
INDIVIOR PLC	+4,64%	2,1 Mrd
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+9,09%	1,97 Mrd
BETTA PHARMACEUTICALS CO., LTD.	-36,86%	1,87 Mrd
VELOXIS PHARMACEUTICALS A/S	-0,50%	1,64 Mrd